Avian-derived monoclonal antibody therapeutic(Pharma Foods International/Mitsubishi Tanabe Pharma)

N/A

Report date: 2024/08/29 11:44:18

Base Information

Drug NameAvian-derived monoclonal antibody therapeutic(Pharma Foods International/Mitsubishi Tanabe Pharma)
Drug Alias NameN/A
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody
Mechanisms of ActionImmunomodulators
TargetsUpdating
Therapy Area/IndicationsInflammationAutoimmune Diseases of the Nervous System
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryJapan
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesPharma Foods International Co LtdMitsubishi Tanabe Pharma Corp
China Registration ClassN/A

Develop Information

Active CompaniesPharma Foods International Co LtdMitsubishi Tanabe Pharma Corp
Inactive CompaniesN/A
Active IndicationsInflammationAutoimmune Diseases of the Nervous System
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A